Argent Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,930
| Closed | -$203K | – | 131 |
|
|
2023
Q1 | $203K | Hold |
2,930
| – | – | 0.1% | 127 |
|
|
2022
Q4 | $211K | Sell |
2,930
-200
| -6% | -$14.4K | 0.11% | 126 |
|
|
2022
Q3 | $223K | Hold |
3,130
| – | – | 0.13% | 118 |
|
|
2022
Q2 | $241K | Buy |
3,130
+50
| +2% | +$3.85K | 0.14% | 112 |
|
|
2022
Q1 | $225K | Sell |
3,080
-1,280
| -29% | -$93.5K | 0.12% | 133 |
|
|
2021
Q4 | $272K | Buy |
4,360
+50
| +1% | +$3.12K | 0.15% | 112 |
|
|
2021
Q3 | $255K | Sell |
4,310
-226
| -5% | -$13.4K | 0.15% | 112 |
|
|
2021
Q2 | $303K | Buy |
4,536
+663
| +17% | +$44.3K | 0.18% | 106 |
|
|
2021
Q1 | $245K | Sell |
3,873
-100
| -3% | -$6.33K | 0.16% | 115 |
|
|
2020
Q4 | $246K | Sell |
3,973
-7,217
| -64% | -$447K | 0.15% | 132 |
|
|
2020
Q3 | $675K | Buy |
11,190
+320
| +3% | +$19.3K | 0.46% | 63 |
|
|
2020
Q2 | $639K | Buy |
10,870
+1,388
| +15% | +$81.6K | 0.49% | 62 |
|
|
2020
Q1 | $529K | Buy |
9,482
+2,630
| +38% | +$147K | 0.53% | 53 |
|
|
2019
Q4 | $449K | Buy |
+6,852
| New | +$449K | 0.34% | 68 |
|